Abstract
Background To halt the spread of COVID-19, Austria implemented a 7-week ‘shut-down’ of public life in March/April 2020 which was followed by a gradual withdrawal of these restriction measures in May/June 2020. We expect that the ensuing reduction in social contacts led to increased loneliness among older adults (60+).
Methods We conducted three analyses to assess the association between COVID-19 public health restriction measures and loneliness: (1) A comparison between pre-pandemic (SHARE: 2013–2017) and pandemic (May 2020) levels of loneliness (UCLA-3 scale), (2) an analysis of the correlation between being affected by COVID-19 restriction measures and loneliness based on cross-sectional survey data from early May 2020, and (3) a longitudinal analysis of weekly changes in loneliness (Corona panel data) from late March to early June 2020.
Results We found (1) loneliness levels to have increased in 2020 in comparison with previous years, (2) an association between the number of restriction measures older adults reported to be affected from and loneliness, and (3) that loneliness was higher during ‘shut-down’ compared to the subsequent re-opening phase, particularly among those who live alone.
Discussion Our results provide evidence that COVID-19 restriction measures in Austria have indeed resulted in increased levels of loneliness among older adults. However, these effects seem to be short-lived, and thus we do not expect strong negative consequences for older adults’ mental health downstream. Nonetheless, effects of longer and/or repeated future restriction measures aiming at social distancing should be closely monitored.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee Med Uni Graz (EK-number 32-368 ex 19/20)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data from the Survey of Health, Ageing and Retirement in Europe (SHARE) is freely accessible for researchers upon registration. The cross-sectional survey data gathered by IFES at the behest of the authors is available upon request, and will be made generally available for scientific use via the Austrian Social Science Data Archive (AUSSDA) later in 2020. The longitudinal data from the Corona panel is already available via AUSSDA. The R-Markdown code reproducing all analyses and results is also available online.
http://www.share-project.org/data-access.html
https://data.aussda.at/dataset.xhtml?persistentId=doi:10.11587/28KQNS
